Business Model
Flexible Strategies to Meet Various Need
Co-development
xNA offers target discovery and ASO drug design tailored to clients' requirements with milestone and shared benefits.
Pipeline License-out
xNA facilitates PCC out-licensing, enabling strategic partnerships and opportunities for potential spin-offs.
Personalized Medicine
xNA customizes ASO targeting clients' mutations or diseases, providing multiple choices of advanced solutions.